Characteristics | Total (N = 1,718) | CNSS (N = 706) | CPSS (N = 1,012) | P |
---|---|---|---|---|
Age | 66.0 (58.0–74.0) | 66.0 (56.0–74.0) | 68.0 (59.0–74.0) | 0.02 |
Male | 1,035 (60.2) | 450 (63.7) | 585 (57.8) | 0.01 |
Past illness | ||||
HTN | 605 (35.2) | 261 (37.0) | 344 (34.0) | 0.20 |
DM | 425 (24.7) | 165 (23.4) | 260 (25.7) | 0.27 |
CAD | 182 (10.6) | 72 (10.2) | 110 (10.9) | 0.66 |
Pulmonary disease | 108 (6.3) | 49 (6.9) | 59 (5.8) | 0.36 |
Malignancy | 782 (45.5) | 302 (42.8) | 480 (47.4) | 0.06 |
Hematologic disorder | 118 (6.9) | 53 (7.5) | 65 (6.4) | 0.39 |
CKD | 238 (13.9) | 128 (18.1) | 110 (10.9) | < 0.01 |
LC | 29 (1.7) | 9 (1.3) | 20 (2.0) | 0.34 |
Initial vital signs | ||||
SBP (mmHg) | 91.0 (80.0–112.0) | 90.0 (80.0–109.0) | 93.0 (80.0–113.0) | 0.28 |
DBP (mmHg) | 58.0 (50.0–69.0) | 58.0 (50.0–68.0) | 58.0 (50.0–71.0) | 0.73 |
PR (/min) | 107.0 (89.0–125.0) | 105.0 (88.0–123.0) | 108.0 (90.0–126.0) | 0.06 |
RR (/min) | 20.0 (20.0–24.0) | 20.0 (20.0–24.0) | 20.0 (20.0–22.0) | 0.04 |
BT (℃) | 37.6 (36.6–38.7) | 37.2 (36.5–38.2) | 37.7 (36.7–38.9) | < 0.01 |
Laboratory | ||||
WBC (× 103/μL) | 9.7 (5.0–15.9) | 10.2 (5.5–16.2) | 9.2 (4.7–15.7) | 0.06 |
Hemoglobin (g/dL) | 10.7 (9.1–12.4) | 10.7 (9.2–12.6) | 10.7 (9.0–12.3) | 0.30 |
PT (INR) | 1.3 (1.1–1.5) | 1.3 (1.1–1.4) | 1.3 (1.1–1.5) | 0.20 |
Lactate (mmol/L) | 2.9 (1.7–5.1) | 2.5 (1.5–4.5) | 3.2 (1.9–5.4) | < 0.01 |
BUN (mg/dL) | 25.0 (17.0–38.0) | 24.0 (17.0–39.0) | 25.0 (17.0–37.0) | 0.95 |
Creatinine (mg/dL) | 1.3 (0.9–2.1) | 1.3 (0.9–2.2) | 1.3 (0.9–2.1) | 0.10 |
Bilirubin (mg/dL) | 1.1 (0.6–2.4) | 0.9 (0.5–1.7) | 1.3 (0.7–3.0) | < 0.01 |
Albumin (g/dL) | 2.6 (2.2–3.1) | 2.6 (2.2–3.1) | 2.6 (2.2–3.1) | 0.37 |
CRP (mg/dL) | 11.6 (5.0–19.8) | 11.1 (4.6–19.2) | 11.9 (5.3–20.2) | 0.02 |
SOFA score | 7.0 (5.0–10.0) | 7.0 (5.0–10.0) | 8.0 (6.0–10.0) | < 0.01 |
Source control | 653 (38.0) | 202 (28.6) | 451 (44.6) | < 0.01 |
Antibiotics escalation | 189 (11.0) | 31 (4.4) | 158 (15.6) | < 0.01 |